Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668
In the original publication [...]
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/15/3/994 |
| _version_ | 1827747992173543424 |
|---|---|
| author | Amira Mansour Mohamed Y. Mahmoud Alaa F. Bakr Monira G. Ghoniem Fatima A. Adam Ibrahim M. El-Sherbiny |
| author_facet | Amira Mansour Mohamed Y. Mahmoud Alaa F. Bakr Monira G. Ghoniem Fatima A. Adam Ibrahim M. El-Sherbiny |
| author_sort | Amira Mansour |
| collection | DOAJ |
| description | In the original publication [...] |
| first_indexed | 2024-03-11T06:01:01Z |
| format | Article |
| id | doaj.art-38e82883965849588ed2b6fa368e1fee |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-11T06:01:01Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-38e82883965849588ed2b6fa368e1fee2023-11-17T13:17:18ZengMDPI AGPharmaceutics1999-49232023-03-0115399410.3390/pharmaceutics15030994Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668Amira Mansour0Mohamed Y. Mahmoud1Alaa F. Bakr2Monira G. Ghoniem3Fatima A. Adam4Ibrahim M. El-Sherbiny5Nanomedicine Research Labs, Center for Materials Science, Zewail City of Science & Technology, Giza 12578, EgyptDepartment of Toxicology and Forensic Medicine, Faculty of Veterinary Medicine, Cairo University, Giza 12211, EgyptDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, EgyptDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi ArabiaDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi ArabiaNanomedicine Research Labs, Center for Materials Science, Zewail City of Science & Technology, Giza 12578, EgyptIn the original publication [...]https://www.mdpi.com/1999-4923/15/3/994n/a |
| spellingShingle | Amira Mansour Mohamed Y. Mahmoud Alaa F. Bakr Monira G. Ghoniem Fatima A. Adam Ibrahim M. El-Sherbiny Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 Pharmaceutics n/a |
| title | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 |
| title_full | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 |
| title_fullStr | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 |
| title_full_unstemmed | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 |
| title_short | Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668 |
| title_sort | correction mansour et al dual enhanced pluronic nanoformulated methotrexate based treatment approach for breast cancer development and evaluation of in vitro and in vivo efficiency i pharmaceutics i 2022 i 14 i 2668 |
| topic | n/a |
| url | https://www.mdpi.com/1999-4923/15/3/994 |
| work_keys_str_mv | AT amiramansour correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 AT mohamedymahmoud correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 AT alaafbakr correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 AT moniragghoniem correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 AT fatimaaadam correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 AT ibrahimmelsherbiny correctionmansouretaldualenhancedpluronicnanoformulatedmethotrexatebasedtreatmentapproachforbreastcancerdevelopmentandevaluationofinvitroandinvivoefficiencyipharmaceuticsi2022i14i2668 |